Celestica: Management And Analysts Upped Guidance/Estimates Still Appear Conservative

I've written quite a few articles on Celestica (NYSE: CLS ). The last one, I rated the company a strong buy. With Q4 2024 earnings in the rearview mirror, I'm adjusting that to a buy. Although, that's a notch lower, thisBram de Haas brings 15 years of investing experience to the table and has over 5 years of experience managing a Euro hedge fund. He is also a former professional poker player and utilizes his bundle of risk management skills to uncover lucrative investments based on special situations.Analys ...